[1] |
左婷婷, 郑荣寿, 曾红梅, 等. 中国肝癌发病状况与趋势分析[J]. 中华肿瘤杂志, 2015, 37(9):691-696.
|
[2] |
应倩, 汪媛. 肝癌流行现况和趋势分析[J]. 中国肿瘤, 2020, 29(3):185-191.
|
[3] |
Lacaze L, Scotté M. Surgical treatment of intra hepatic recurrence of hepatocellular carcinoma[J]. World J Hepatol, 2015, 7(13):1755-1760.
|
[4] |
黄建钊, 刘江伟, 孙倩, 等. 射频消融与手术切除治疗肝癌的疗效比较[J]. 广东医学, 2012, 33(13):1991-1993.
|
[5] |
Yamashita Y, Tsuijita E, Takeishi K, et al. Trends in surgical results of hepatic resection for hepatocellular carcinoma: 1,000 consecutive cases over 20 years in a single institution[J]. Am J Surg, 2014, 207(6):890-896.
|
[6] |
Nakayama H, Takayama T. Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma[J]. World J Hepatol, 2015, 7(2):261-269.
|
[7] |
中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017年版)[J]. 中华消化外科杂志, 2017, 16(7):635-647.
|
[8] |
Toshiyuki I, Hideki N, Hironobu A, et al. Repeat hepatectomy for recurrent hepatocellular carcinoma[J]. Surgery, 2007, 141(5):589-597.
|
[9] |
Xia Y, Li J, Liu G, et al. Long-term effects of repeat hepatectomy vs percutaneous radiofrequency ablation among patients with recurrent hepatocellular carcinoma: a randomized clinical trial[J]. JAMA Oncol, 2020, 6(2):255-263.
|
[10] |
Chan DL, Morris DL, Chua TC. Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma-a systematic review[J]. Surg Oncol, 2013, 22(2):e22-30.
|
[11] |
Zhou Y, Sui C, Li B, et al. Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review[J]. World J Surg Oncol, 2010(8):55.
|
[12] |
Erridge S, Pucher PH, Markar SR, et al. Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma[J]. Br J Surg, 2017, 104(11):1433-1442.
|
[13] |
Makino Y, Yamanoi A, Kimoto T, et al. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma[J]. Am J Gastroenterol, 2000, 95(5): 1294-1300.
|
[14] |
Xu RH, Gao W, Wang C, et al. Systematic evaluation of percutaneous radiofrequency ablation versus percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: a meta-analysis[J]. Eur J Med Res, 2014, 19(1):39.
|
[15] |
杨藩, 张二雷, 童兵, 等. 对比经皮微波消融与手术切除治疗合并肝硬化的单发小肝癌疗效分析[J]. 肝胆外科杂志, 2015, 23(6): 421-425.
|
[16] |
周传力, 张珍, 徐亚吉, 等. 经皮微波消融与手术切除治疗原发性小肝癌疗效Meta分析[J]. 四川生理科学杂志, 2019, 41(2): 103-107.
|
[17] |
肖梅. 腹腔镜微波消融治疗肝癌的策略分析[J]. 中国医刊, 2015, 50(2):7-9.
|
[18] |
Kang TW,Kim JM,Rhim H,et al. Small hepatocellular carcinoma: radiofrequency ablation versus nonanatomic resection--propensity score analyses of long-term outcomes[J]. Radiology,2015, 275(3): 908-919.
|
[19] |
Fang Y, Chen W, Liang X, et al. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma[J]. Gastroenterol Hepatol, 2014,29(1):193-200.
|
[20] |
蒋恒, 万圣云, 侯辉, 等. 肝癌复发后再次肝切除与射频消融疗效的Meta分析[J]. 中华普通外科杂志, 2015, 30(2):146-149.
|
[21] |
冯国英, 李佳明, 杨旭, 等. 重复肝切除术与射频消融术治疗复发性肝癌疗效对比的Meta分析[J]. 重庆医学, 2021, 50(10): 1753-1759.
|
[22] |
张婷婷, 李开艳, 张伟, 等. 经皮微波消融治疗术后复发性肝癌的长期生存影响因素分析[J]. 中华超声影像学杂志, 2013, 22(11):957-961.
|
[23] |
Sparchez Z, Mocan T, Radu P, et al. Prognostic factors after percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma. impact of incomplete ablation on recurrence and overall survival rates[J]. J Gastrointestin Liver Dis, 2018, 27(4):399-407.
|
[24] |
冯含昕, 赵阳, 徐锋, 等. 微波消融技术在肝癌治疗的应用现状和展望[J/CD]. 中华普通外科学文献(电子版), 2020, 14(6):458-462.
|
[25] |
史瑶平, 翟博. 肝癌局部治疗——消融或切除?[J].临床肝胆病杂志, 2021, 37(3):506-509.
|